[Glucagon-like peptide-1 based therapy for type 2 diabetes].
Yu
Bao-sheng
BS
D002648:Child; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D052216:Glucagon-Like Peptide 1 / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D054795:Incretins / Q000627:therapeutic use*; D016896:Treatment Outcome
D054795:Incretins; D052216:Glucagon-Like Peptide 1